CGP enabled by next-generation sequencing (NGS) technology allows all known biomarkers to be evaluated in a single test.
Learn about CGP and the potential for oncologists to unlock new treatment options for their patients, from approved therapies to clinical trials.
QB8336
This video was provided by Illumina.
